Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
CF Industries Holdings Inc.’s ( CF - Analyst Report ) third-quarter 2012 adjusted earnings (excluding one-time gains) of $5.85 per share exceeded the Zacks Consensus Estimate of $5.82. After including one-time items, the company earned $6.35 a share in the quarter, up 34.2% from $4.73 in the year-ago quarter.
Sales were down 3.2% to $1.36 billion in the quarter from $1.40 billion in the prior-year quarter. However, it edged past the Zacks Consensus Estimate of $1.35 billion. Lower nitrogen volume and phosphate product pricing led to the decline in sales. Total sales volumes decreased 2% year over year to 3.5 million tons due to lower urea sales.
Costs and Margins
Cost of sales stood at $657.4 million compared with $765.8 million in the year-earlier quarter. Gross profit increased 10% to $702 million in the quarter. Selling, general and administrative expenses jumped 19.7% to $36.5 million from $30.5 million in the year-ago quarter. The company reported an operating income of $667.1 million, up 14.6% from $582.3 million in the prior-year quarter.
Segmental Performance
Nitrogen Segment
Sales were flat year over year at $1.1 billion. Gross margin spiked 16% to $638.6 million. Total sales volumes were down 3% year over year to 3 million tons in the quarter. Cost of sales declined in the quarter due to lower realized natural gas costs. Natural gas production was high during the quarter and amount of natural gas in storage was also high. The realized natural gas price in the quarter declined to $3.34 per MMBtu from $4.45 a year ago.
Phosphate Segment
Sales declined 8% year over year to $264.2 million. Gross margin declined 26% to $63.4 million due to lower prices. Volumes sold in the quarter were 517,000 tons, up from 505,000 tons a year ago, attributed to higher domestic sales as customers sought to rebuild inventory in anticipation of strong demand from high expected corn plantings next year. The average selling prices of diammonium phosphate (DAP) and monoammonium phosphate (MAP) were $507 and $521, respectively, down 10.4% and 8.1% year over year.
Financial Position
Cash and cash equivalents totaled $2.22 billion as of September 30, 2012, compared with $1.21 billion as of December 31, 2011. Long-term debt stood at $1.60 billion as of September 30, 2012, compared with $1.61 billion as of December 31, 2011.
Outlook
CF Industries remains positive for the remainder of 2012 as well as 2013 based on high corn planting expectations for 2013, strong domestic fertilizer demand, tight domestic nitrogen supply and favorable natural gas costs. The company expects capital expenditures to be in the range of $350-$400 million in 2012 (excluding spending on the new capacity expansion projects).
CF Industries competes with Agrium Inc. ( AGU - Analyst Report ) and Potash Corp. of Saskatchewan Inc. ( POT - Analyst Report ) . Currently, the company maintains a Zacks #3 Rank, which translates into a short-term (1 to 3 months) “Hold” rating. We have a long-term (more than 6 months) “Neutral” recommendation on its shares.
Read the full reports :
Analyst Report on POT
Analyst Report on CF
Analyst Report on AGU